Ethyrealbio
Cambridge, US · 14 employees on LinkedIn · 3 known investors
Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.
Founders & leadership
NK
Niranjan KameswaraninChief Executive Officer
JS
Jessica StrommeinChief Development Officer
KF
Kelly FosterinChief Scientific Officer
SH
Stephen HuanginSenior Vice President, Head of Clinical Development
Board
SR
Simon ReadChairman of the Board and Independent Board Member
Investors · 3
Frequently asked questions
- What does Ethyrealbio do?
- Ethyreal Bio is a biopharmaceutical company developing medicines for people with Thyroid Eye Disease and Graves' Disease. It focuses on antibody and other therapeutic programs in the endocrine/immunology space.
- Who are Ethyrealbio's investors?
- Ethyrealbio's investors include Atlas Venture, Avoro Capital Advisors, Medicxi.
- Where is Ethyrealbio headquartered?
- Ethyrealbio is headquartered in Cambridge, US.